For many years Applied Biosystems has continued to provide robust, reliable tools to analyse DNA and RNA, small molecules, and proteins, in order to make scientific discoveries, develop new pharmaceuticals and conduct standardised testing. Applied Biosystems has developed and introduced dozens of technologies that have catalysed the genomic and proteomics revolutions and are now essential to life science research and applied fields. The company’s biggest contribution has almost certainly been in the development and commercialisation of robust and reliable DNA sequencer technology, and the provision of quality reagents and consumables needed to ensure effective and comparable experimental data. Through the years, our DNA sequencers have remained the gold standard. The first automated DNA sequencer, introduced in 1986, could run 16 samples in a 12-hour cycle, analysing approximately 4,800 base pairs of DNA per day.
Sorry, this page is available to members only.
If you have not registered with us yet, why not
register today for FREE and receive exclusive online access. Interested in receiving European Pharmaceutical Review in print? Subscribe today and guarantee the next six issues delivered direct to your desk, plus gain exclusive access online.